OrbiMed Advisors LLC's Form 4 filing
Electra Therapeutics, Inc.ETRA · filed Nov 10, 2026
- Accession no.
- 0000947871-26-001010
- Filed
- Nov 10, 2026, 8:09 PM ET
- Trade date
- Nov 6-10, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market purchases total $744.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director, 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | Director, 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Common Stock | PPurchaseAcquired | +9,816 | $7.85 | +$77,055.6 | 5,230,578 | Indirect | |
| Nov 6, 2026 | Common Stock | PPurchaseAcquired | +39,600 | $7.85 | +$310,860 | 2,176,579 | Indirect | |
| Nov 9, 2026 | Common Stock | PPurchaseAcquired | +4,000 | $8.24 | +$32,960 | 5,234,578 | Indirect | |
| Nov 9, 2026 | Common Stock | PPurchaseAcquired | +16,000 | $8.24 | +$131,840 | 2,192,579 | Indirect | |
| Nov 10, 2026 | Common Stock | PPurchaseAcquired | +20,700 | $8.45 | +$174,915 | 5,255,278 | Indirect | |
| Nov 10, 2026 | Common Stock | PPurchaseAcquired | +2,000 | $8.45 | +$16,900 | 2,194,579 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.